Advertisement MHRA cautions diabetic patients against Wockhardt UK insulin cartridges - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

MHRA cautions diabetic patients against Wockhardt UK insulin cartridges

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, has asked diabetic patients using Hypurin Porcine Isophane insulin cartridges to check their medication following a packaging error.

The error came to light when intermediate acting Hypurin Porcine Isophane Insulin 100 IU/ml cartridges carton got into the production line for the short acting Hypurin Porcine Neutral Insulin 100IU/ml.

The issue relates to one batch of Hypurin Porcine Neutral Insulin produced by Wockhardt UK with the batch number PL40147.

MHRA has also directed pharmacists and wholesalers to check Hypurin Porcine Isophane Insulin stocks and contact Wockhardt if any packs of the insulin printed with the batch number, are identified.

Cartons of Hypurin Porcine Neutral Insulin 100 IU/ml with the same lot number are not included in the recall and should not be returned, MHRA added.

MHRA Inspection director Enforcement and Standards Gerald Heddell said it is important that patients continue to administer their insulin as required.

"Patients with any questions or concerns should contact their GP or pharmacist as soon as possible,” Heddell added.

"An investigation has taken place and action has been taken to rectify the issue."